Suppr超能文献

CCR1 与 CCR2 的交叉脱敏作用在 FPR1 激活后发生。

Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1.

机构信息

Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140; and.

Center for Inflammation, Translational and Clinical Lung Research, Temple University School of Medicine, Philadelphia, PA 19140.

出版信息

J Immunol. 2014 Jun 1;192(11):5305-13. doi: 10.4049/jimmunol.1302983. Epub 2014 Apr 28.

Abstract

The cross-regulation of G protein-coupled receptors (GPCRs) plays an important role in the immune response. Studies from several laboratories have suggested that a hierarchy of sensitivities to cross-desensitization exists for the chemoattractant GPCRs. We carried out experiments to study the capacity of the formyl peptide receptor-1 (FPR1) to desensitize chemokine receptors CCR1 and CCR2. Our results show that activation of FPR1 resulted in the desensitization and partial internalization of CCR1, but not CCR2, in both primary human monocytes and HEK293 cells coexpressing CCR1, CCR2, and FPR1 (HR1R2F cells). The desensitization of CCR1 by FPR1 stimulation was not due to the simple depletion of the Ca(2+) stores, but was dependent on activation of protein kinase C. Furthermore, we found that the cross-desensitization of CCR1 by FPR1 was associated with CCR1 phosphorylation and moderate reduction of CCR1 cell-surface expression. In contrast, CCR2 was not phosphorylated or internalized after FPR1 activation. Additional studies showed that optimal cross talk between FPR1 and CCR1 was dependent on the functional activity of protein kinase Cβ. These results provide a mechanistic basis for the capacity of certain GPCR ligands to exert rapid and selective cross-inactivation of other chemoattractant receptors, and suggest that FPR1 is able to exert "traffic control" in the migration of inflammatory cells by rapidly inhibiting the cell responses to potentially "low-priority" chemoattractants such as CCR1 agonists without inhibiting the response to "higher priority" CCR2 chemoattractants.

摘要

G 蛋白偶联受体(GPCR)的交叉调节在免疫反应中起着重要作用。来自几个实验室的研究表明,趋化因子 GPCR 的交叉脱敏敏感性存在一个层次结构。我们进行了实验来研究甲酰肽受体-1(FPR1)使趋化因子受体 CCR1 和 CCR2 脱敏的能力。我们的结果表明,FPR1 的激活导致人原代单核细胞和共表达 CCR1、CCR2 和 FPR1(HR1R2F 细胞)的 HEK293 细胞中 CCR1 的脱敏和部分内化,但不影响 CCR2。FPR1 刺激引起的 CCR1 脱敏不是由于 Ca(2+)储存的简单耗竭,而是依赖于蛋白激酶 C 的激活。此外,我们发现 FPR1 引起的 CCR1 交叉脱敏与 CCR1 磷酸化和 CCR1 细胞表面表达的适度减少有关。相比之下,FPR1 激活后 CCR2 未发生磷酸化或内化。进一步的研究表明,FPR1 和 CCR1 之间的最佳交叉对话依赖于蛋白激酶 Cβ的功能活性。这些结果为某些 GPCR 配体能够快速且选择性地使其他趋化因子受体失活提供了机制基础,并表明 FPR1 能够通过快速抑制细胞对潜在的“低优先级”趋化因子(如 CCR1 激动剂)的反应而对炎症细胞的迁移施加“交通控制”,而不会抑制对“高优先级”CCR2 趋化因子的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed86/4035699/a41cb58d456a/nihms581502f1.jpg

相似文献

引用本文的文献

3
Systemic mechanisms of necrotic cell debris clearance.坏死细胞碎片清除的全身机制。
Cell Death Dis. 2024 Aug 1;15(8):557. doi: 10.1038/s41419-024-06947-5.
8
Bidirectional Regulation of Opioid and Chemokine Function.阿片类物质和趋化因子功能的双向调节。
Front Immunol. 2020 Jan 31;11:94. doi: 10.3389/fimmu.2020.00094. eCollection 2020.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验